CIK 0001178253
- Non-accelerated filer
- Smaller reporting company
SCYNEXIS INC
Sign in to watch- Ticker
- SCYX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 562181648
- Phone
- +1 201-884-5485
- Business address
- 1 EVERTRUST PLAZA, 13TH FLOOR, JERSEY CITY, NJ, 07302-6548
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-05-07 | Arthaud Laurent Director | Option exercise · Common Stock Warrant (right to buy) | −34 | 0 | ||
| 2014-05-07 | Arthaud Laurent Director | Option exercise · Common Stock Warrant (right to buy) | −222 | 0 | ||
| 2014-05-07 | Arthaud Laurent Director | Conversion · Series D-1 Preferred Stock | −8,127 | 0 | ||
| 2014-05-07 | Arthaud Laurent Director | Conversion · Series D-2 Preferred Stock | −1,665 | 0 | ||
| 2014-05-07 | FCPR Biotechnology Fund 10% owner | Option exercise | +5,251 | $0.20 | $1K | 5,251 |
| 2014-05-07 | FCPR Biotechnology Fund 10% owner | Option exercise | +5,251 | $0.20 | $1K | 10,502 |
| 2014-05-07 | FCPR Biotechnology Fund 10% owner | Option exercise | +25,998 | $0.20 | $5K | 36,500 |
| 2014-05-07 | FCPR Biotechnology Fund 10% owner | Conversion | +46,863 | 83,363 | ||
| 2014-05-07 | FCPR Biotechnology Fund 10% owner | Conversion | +88,796 | 172,159 | ||
| 2014-05-07 | FCPR Biotechnology Fund 10% owner | Conversion | +42,336 | 214,495 | ||
| 2014-05-07 | FCPR Biotechnology Fund 10% owner | Conversion | +30,582 | 245,077 | ||
| 2014-05-07 | FCPR Biotechnology Fund 10% owner | Purchase | +50,000 | $10.00 | $500K | 295,077 |
| 2014-05-07 | FCPR Biotechnology Fund 10% owner | Option exercise · Common Stock Warrant (right to buy) | −5,251 | 0 | ||
| 2014-05-07 | FCPR Biotechnology Fund 10% owner | Option exercise · Common Stock Warrant (right to buy) | −5,251 | 0 | ||
| 2014-05-07 | FCPR Biotechnology Fund 10% owner | Option exercise · Common Stock Warrant (right to buy) | −25,998 | 0 | ||
| 2014-05-07 | FCPR Biotechnology Fund 10% owner | Conversion · Series B Preferred Stock | −166,482 | 0 | ||
| 2014-05-07 | FCPR Biotechnology Fund 10% owner | Conversion · Series C Preferred Stock | −313,996 | 0 | ||
| 2014-05-07 | FCPR Biotechnology Fund 10% owner | Conversion · Series D-1 Preferred Stock | −863,672 | 0 | ||
| 2014-05-07 | FCPR Biotechnology Fund 10% owner | Conversion · Series D-2 Preferred Stock | −623,880 | 0 | ||
| 2014-05-07 | Nothias Jean-Yves Director | Option exercise | +5,251 | $0.20 | $1K | 5,251 |
Page 22 of 26 · 507 trades